Fifth Third Bancorp’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Fifth Third Bancorp’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-111	Closed	-$1K	–	2776
2021 Q2	$1K	Hold	111	–	–	﹤0.01%	2406
2021 Q1	$1K	Hold	111	–	–	﹤0.01%	2389
2020 Q4	$4K	Hold	111	–	–	﹤0.01%	2157
2020 Q3	$2K	Hold	111	–	–	﹤0.01%	2097
2020 Q2	$2K	Hold	111	–	–	﹤0.01%	1994
2020 Q1	$1K	Hold	111	–	–	﹤0.01%	2079
2019 Q4	$3K	Hold	111	–	–	﹤0.01%	2035
2019 Q3	$2K	Hold	111	–	–	﹤0.01%	2078
2019 Q2	$1K	Hold	111	–	–	﹤0.01%	2224
2019 Q1	$2K	Hold	111	–	–	﹤0.01%	2071
2018 Q4	$2K	Hold	111	–	–	﹤0.01%	2131
2018 Q3	$2K	Hold	111	–	–	﹤0.01%	2109
2018 Q2	$5K	Hold	111	–	–	﹤0.01%	2064
2018 Q1	$7K	Hold	111	–	–	﹤0.01%	2000
2017 Q4	$8K	Hold	111	–	–	﹤0.01%	1904
2017 Q3	$10K	Hold	111	–	–	﹤0.01%	1778
2017 Q2	$7K	Hold	111	–	–	﹤0.01%	1834
2017 Q1	$24K	Hold	111	–	–	﹤0.01%	1527
2016 Q4	$10K	Hold	111	–	–	﹤0.01%	1803
2016 Q3	$15K	Hold	111	–	–	﹤0.01%	1719
2016 Q2	$11K	Hold	111	–	–	﹤0.01%	1781
2016 Q1	$18K	Hold	111	–	–	﹤0.01%	1663
2015 Q4	$36K	Hold	111	–	–	﹤0.01%	1495
2015 Q3	$36K	Buy	+111	New	+$48.8K	﹤0.01%	1513

Other funds holding LUMO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Fifth Third Bancorp's LUMO Position: Q3 2021 in Review

Fifth Third Bancorp sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2021, closing a stake of 111 shares — an estimated $1K sold.

Fifth Third Bancorp first reported a position in LUMO in Q3 2015 and held it in 24 quarters. The position peaked at $36K in Q4 2015. 37 funds tracked by Wall St. Rank hold LUMO as of Q3 2021.

Fifth Third Bancorp reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Fifth Third Bancorp sold 111 Lumos Pharma, Inc. Common Stock shares in Q3 2021, an estimated $1K.
Fifth Third Bancorp first reported a position in Lumos Pharma, Inc. Common Stock in Q3 2015 and held it in 24 quarters.
Fifth Third Bancorp's Lumos Pharma, Inc. Common Stock position peaked at $36K in Q4 2015.
37 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2021.

Based on Fifth Third Bancorp's 13F filing for Q3 2021, filed 15 Oct 2021.